Skip to main content
$15.82 +0.66 (+4.32%)
Market Cap
$257.14M
Shares
16.96M

Q32 Bio Inc. Earnings Call Transcripts

Every quarterly earnings call for Q32 Bio Inc. (QTTB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q1
2026-05-05
Q32 Bio Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.54
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
Q32 Bio Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Q32 Bio Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-0.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Q32 Bio Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-0.78
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Q32 Bio Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-0.90
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Q32 Bio Inc. Q4 FY2024 Earnings Call
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Q32 Bio Inc. Q3 FY2024 Earnings Call
Revenue
$
Diluted EPS
$-1.46
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Q32 Bio Inc. Q2 FY2024 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-1.42
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Q32 Bio Inc. Q4 FY2023 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Q32 Bio Inc. Q3 FY2020 Earnings Call
Revenue
$567,000
▲ 28.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 earnings calls
Key facts CIK 1661998 CUSIP 746964105 13F (30d) 10 filings 10 filers Visit website Investor relations